These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 28718964)

  • 21. Antiangiogenic and Antitumor Activities of Aflibercept, a Soluble VEGF Receptor-1 and -2, in a Mouse Model of Hepatocellular Carcinoma.
    Torimura T; Iwamoto H; Nakamura T; Abe M; Ikezono Y; Wada F; Sakaue T; Masuda H; Hashimoto O; Koga H; Ueno T; Yano H
    Neoplasia; 2016 Jul; 18(7):413-24. PubMed ID: 27435924
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Magnolol suppresses vascular endothelial growth factor-induced angiogenesis by inhibiting Ras-dependent mitogen-activated protein kinase and phosphatidylinositol 3-kinase/Akt signaling pathways.
    Kim KM; Kim NS; Kim J; Park JS; Yi JM; Lee J; Bang OS
    Nutr Cancer; 2013; 65(8):1245-53. PubMed ID: 24066970
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Magnolol suppresses hypoxia-induced angiogenesis via inhibition of HIF-1α/VEGF signaling pathway in human bladder cancer cells.
    Chen MC; Lee CF; Huang WH; Chou TC
    Biochem Pharmacol; 2013 May; 85(9):1278-87. PubMed ID: 23416116
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The chemopreventive agent oltipraz possesses potent antiangiogenic activity in vitro, ex vivo, and in vivo and inhibits tumor xenograft growth.
    Ruggeri BA; Robinson C; Angeles T; Wilkinson J; Clapper ML
    Clin Cancer Res; 2002 Jan; 8(1):267-74. PubMed ID: 11801568
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ziyuglycoside II exerts antiproliferative and antimetastasis effects on hepatocellular carcinoma cells.
    Liao W; Fan L; Zheng Z; Liu H; Deng H; Li M; Liu F; Yang A
    Anticancer Drugs; 2020 Sep; 31(8):819-827. PubMed ID: 32097137
    [TBL] [Abstract][Full Text] [Related]  

  • 26. NSK-01105, a novel sorafenib derivative, inhibits human prostate tumor growth via suppression of VEGFR2/EGFR-mediated angiogenesis.
    Yu P; Ye L; Wang H; Du G; Zhang J; Zuo Y; Zhang J; Tian J
    PLoS One; 2014; 9(12):e115041. PubMed ID: 25551444
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Raddeanin A, a triterpenoid saponin isolated from Anemone raddeana, suppresses the angiogenesis and growth of human colorectal tumor by inhibiting VEGFR2 signaling.
    Guan YY; Liu HJ; Luan X; Xu JR; Lu Q; Liu YR; Gao YG; Zhao M; Chen HZ; Fang C
    Phytomedicine; 2015 Jan; 22(1):103-10. PubMed ID: 25636878
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Widdrol, a sesquiterpene isolated from Juniperus chinensis, inhibits angiogenesis by targeting vascular endothelial growth factor receptor 2 signaling.
    Jin S; Yun HJ; Jeong HY; Oh YN; Park HJ; Yun SG; Kim BW; Kwon HJ
    Oncol Rep; 2015 Sep; 34(3):1178-84. PubMed ID: 26133679
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Orally Administered Mucolytic Drug l-Carbocisteine Inhibits Angiogenesis and Tumor Growth in Mice.
    Shinya T; Yokota T; Nakayama S; Oki S; Mutoh J; Takahashi S; Sato K
    J Pharmacol Exp Ther; 2015 Sep; 354(3):269-78. PubMed ID: 26126534
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Scopoletin, an active principle of tree tobacco (Nicotiana glauca) inhibits human tumor vascularization in xenograft models and modulates ERK1, VEGF-A, and FGF-2 in computer model.
    Tabana YM; Hassan LE; Ahamed MB; Dahham SS; Iqbal MA; Saeed MA; Khan MS; Sandai D; Majid AS; Oon CE; Majid AM
    Microvasc Res; 2016 Sep; 107():17-33. PubMed ID: 27133199
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phostine 3.1a as a pharmacological compound with antiangiogenic properties against diseases with excess vascularization.
    Bousseau S; Marchand M; Soleti R; Vergori L; Hilairet G; Recoquillon S; Le Mao M; Gueguen N; Khiati S; Clarion L; Bakalara N; Martinez MC; Germain S; Lenaers G; Andriantsitohaina R
    FASEB J; 2019 May; 33(5):5864-5875. PubMed ID: 30817178
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ziyuglycoside II induces cell cycle arrest and apoptosis through activation of ROS/JNK pathway in human breast cancer cells.
    Zhu X; Wang K; Zhang K; Zhu L; Zhou F
    Toxicol Lett; 2014 May; 227(1):65-73. PubMed ID: 24680927
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of Antiangiogenic Efficacy of Emilia sonchifolia (L.) DC on Tumor-Specific Neovessel Formation by Regulating MMPs, VEGF, and Proinflammatory Cytokines.
    Gilcy GK; Kuttan G
    Integr Cancer Ther; 2016 Dec; 15(4):NP1-NP12. PubMed ID: 27146127
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibitory effects of Sanguisorba officinalis root extract on HYBID (KIAA1199)-mediated hyaluronan degradation and skin wrinkling.
    Yoshida H; Yamazaki K; Komiya A; Aoki M; Kasamatsu S; Murata T; Sayo T; Cilek MZ; Okada Y; Takahashi Y
    Int J Cosmet Sci; 2019 Feb; 41(1):12-20. PubMed ID: 30485450
    [TBL] [Abstract][Full Text] [Related]  

  • 35. DCLAK11, a multi-tyrosine kinase inhibitor, exhibits potent antitumor and antiangiogenic activity in vitro.
    Guo XB; Chen XJ; Tong LJ; Peng X; Huang M; Liu HC; Liu H; Ding J
    Acta Pharmacol Sin; 2015 Oct; 36(10):1266-76. PubMed ID: 26027659
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Realgar transforming solution suppresses angiogenesis and tumor growth by inhibiting VEGF receptor 2 signaling in vein endothelial cells.
    Song P; Hai Y; Wang X; Zhao L; Chen B; Cui P; Xie Q; Yu L; Li Y; Wu Z; Li H
    Arch Pharm Res; 2018 Apr; 41(4):467-480. PubMed ID: 29542005
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ZLM-7 exhibits anti-angiogenic effects via impaired endothelial cell function and blockade of VEGF/VEGFR-2 signaling.
    Su M; Huang J; Li J; Qin X; Tang X; Jin F; Chen S; Jiang C; Zou Z; Peng K; Nuruzzaman M; Zhang J; Luo J; Liu S; Luo Z
    Oncotarget; 2016 Apr; 7(14):19018-30. PubMed ID: 26967559
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anti-Diabetic and Hepato-Renal Protective Effects of Ziyuglycoside II Methyl Ester in Type 2 Diabetic Mice.
    Son DJ; Hwang SY; Kim MH; Park UK; Kim BS
    Nutrients; 2015 Jul; 7(7):5469-83. PubMed ID: 26198246
    [TBL] [Abstract][Full Text] [Related]  

  • 39. α-Tocopherol suppresses antiangiogenic effect of δ-tocotrienol in human umbilical vein endothelial cells.
    Shibata A; Nakagawa K; Tsuduki T; Miyazawa T
    J Nutr Biochem; 2015 Apr; 26(4):345-50. PubMed ID: 25662730
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The anti-angiogenic action of 2-deoxyglucose involves attenuation of VEGFR2 signaling and MMP-2 expression in HUVECs.
    Chuang IC; Yang CM; Song TY; Yang NC; Hu ML
    Life Sci; 2015 Oct; 139():52-61. PubMed ID: 26285173
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.